KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $151,378,000 | +224.8% | 841,880 | +87.3% | 0.04% | +208.3% |
Q2 2017 | $46,608,000 | +133.6% | 449,580 | +76.8% | 0.01% | +100.0% |
Q1 2017 | $19,956,000 | +299.6% | 254,244 | +128.3% | 0.01% | +500.0% |
Q4 2016 | $4,994,000 | -83.0% | 111,386 | -78.8% | 0.00% | -88.9% |
Q3 2016 | $29,325,000 | +661.1% | 524,968 | +581.2% | 0.01% | +800.0% |
Q2 2016 | $3,853,000 | -48.9% | 77,062 | -53.1% | 0.00% | -66.7% |
Q1 2016 | $7,536,000 | -12.2% | 164,183 | +17.9% | 0.00% | 0.0% |
Q4 2015 | $8,581,000 | -4.1% | 139,263 | -13.3% | 0.00% | 0.0% |
Q3 2015 | $8,947,000 | +23.1% | 160,683 | +34.8% | 0.00% | 0.0% |
Q2 2015 | $7,269,000 | +191.5% | 119,226 | +175.8% | 0.00% | +200.0% |
Q1 2015 | $2,494,000 | – | 43,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $185,086,000 | 58.62% |
BAINCO INTERNATIONAL INVESTORS | 879,840 | $69,059,000 | 9.77% |
Coastal Bridge Advisors, LLC | 235,140 | $18,456,000 | 6.29% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,433,899 | $112,547,000 | 5.71% |
NEXTHERA CAPITAL LP | 105,000 | $8,241,000 | 4.20% |
ARK Investment Management | 87,364 | $6,857,000 | 1.98% |
Casdin Capital, LLC | 42,500 | $3,336,000 | 1.97% |
BB BIOTECH AG | 740,000 | $58,083,000 | 1.90% |
FT Options LLC | 81,700 | $1,287,000 | 1.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 55,500 | $4,346,000 | 1.66% |